The human cathelicidin LL-37 is one of the most promising candidates for replacing standard antibiotics due to its broad-spectrum activity and low propensity for resistance development. However, the widespread clinical adoption of antimicrobial peptides (AMPs) is currently limited by the high cost and several constraints of traditional chemical synthesis. Recombinant expression offers a cost-effective and scalable alternative, although challenges including host toxicity and low expression yields remain. In previous studies, the human elastin-like polypeptide (HELP) carrier effectively mitigated host toxicity, enhanced protein solubility, and enabled simple and convenient purification of antimicrobial domains through its thermo-responsive phase-transition properties. Here, we report the recombinant production of H1FK16, a non-cytotoxic polypeptide in which FK16, a bioactive LL-37-derived peptide, is genetically fused to the HELP carrier. Its production yield was comparable to that of the carrier, with an average of 180 mg of fusion protein per liter of bacterial culture. The construct was designed to retain an upstream glutamic acid residue that enables site-specific FK16 release by glutamyl endopeptidase, a proteolytic activity associated with Staphylococcus aureus virulence. The released FK16 domain retained its antimicrobial activity against both Gram-positive S. aureus and Gram-negative Escherichia coli, exhibiting a minimum inhibitory concentration of 2.5 µM, comparable to reported values. The findings highlight the potential of this fusion system as a versatile platform for developing biocompatible materials that selectively target pathogenic microorganisms through enzymatically triggered release of antimicrobial domains.

Evaluation of a cathelicidin derivative fusion polypeptide for pathogen-targeted antimicrobial approach / Colomina-Alfaro, L., Lee, M., Zhang, S., Sist, P., Urbani, R., Shaalan, A., Di Silvio, L., Stamboulis, A., Ren, Q., Bandiera, A.. - In: APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. - ISSN 1432-0614. - (2026), pp. "-"-"-". [Epub ahead of print] [10.1007/s00253-026-14037-z]

Evaluation of a cathelicidin derivative fusion polypeptide for pathogen-targeted antimicrobial approach

Colomina-Alfaro, Laura;Sist, Paola;Urbani, Ranieri;Bandiera, Antonella
2026-01-01

Abstract

The human cathelicidin LL-37 is one of the most promising candidates for replacing standard antibiotics due to its broad-spectrum activity and low propensity for resistance development. However, the widespread clinical adoption of antimicrobial peptides (AMPs) is currently limited by the high cost and several constraints of traditional chemical synthesis. Recombinant expression offers a cost-effective and scalable alternative, although challenges including host toxicity and low expression yields remain. In previous studies, the human elastin-like polypeptide (HELP) carrier effectively mitigated host toxicity, enhanced protein solubility, and enabled simple and convenient purification of antimicrobial domains through its thermo-responsive phase-transition properties. Here, we report the recombinant production of H1FK16, a non-cytotoxic polypeptide in which FK16, a bioactive LL-37-derived peptide, is genetically fused to the HELP carrier. Its production yield was comparable to that of the carrier, with an average of 180 mg of fusion protein per liter of bacterial culture. The construct was designed to retain an upstream glutamic acid residue that enables site-specific FK16 release by glutamyl endopeptidase, a proteolytic activity associated with Staphylococcus aureus virulence. The released FK16 domain retained its antimicrobial activity against both Gram-positive S. aureus and Gram-negative Escherichia coli, exhibiting a minimum inhibitory concentration of 2.5 µM, comparable to reported values. The findings highlight the potential of this fusion system as a versatile platform for developing biocompatible materials that selectively target pathogenic microorganisms through enzymatically triggered release of antimicrobial domains.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3151459
 Avviso

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact